The Patent Finder

Ardea Biosciences, Inc.

Also on record
Records under this name other than the patents Ardea Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Back to Ardea Biosciences, Inc.

PatentTitleStatus Expires Confidence
US 10,047,0503,4-DI-SUBSTITUTED Pyridine Compound, Methods of Using and Compositions Comprising the Same
Lapsed on the fee record
Ended Aug 14, 2026 · High confidence
Lapsed on the fee recordEnded Aug 14, 2026High confidence
US 7,435,752N[S(4-ARYL-TRIAZOL-3-YL)ALPHA-MERCAPTOACETYL]-P-AMINO Benzoic Acids as HIV Reverse Transcriptase Inhibitors
Term ended
Ended no later than Apr 1, 2026 · Medium confidence
Term endedEnded no later than Apr 1, 2026Medium confidence
US 7,947,721S-Triazolyl Alpha-Mercaptoacetanilides as Inhibitors of HIV Reverse Transcriptase
Term ended
Term ended Aug 25, 2025 · Medium confidence
Term endedTerm ended Aug 25, 2025Medium confidence
US 8,003,6812-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-YL)-4H-1,2,4-Triazol-3-Ylthio)ACETIC Acid and Methyl Ester
Term ended
Term ended Aug 25, 2025 · High confidence
Term endedTerm ended Aug 25, 2025High confidence
US 8,252,828S-Triazolyl Alpha-Mercapto Acetanilides as Inhibitors of HIV Reverse Transcriptase
Term ended
Term ended Aug 25, 2025 · Medium confidence
Term endedTerm ended Aug 25, 2025Medium confidence
US 8,481,581S-Triazolyl Alpha-Mercapto Acetanilides as Inhibitors of HIV Reverse Transcriptase
Term ended
Term ended Aug 25, 2025 · High confidence
Term endedTerm ended Aug 25, 2025High confidence
US 8,946,273S-Triazolyl Alpha-Mercaptoacetanilides as Inhibitors of HIV Reverse Transcriptase
Term ended
Term ended Aug 25, 2025 · Medium confidence
Term endedTerm ended Aug 25, 2025Medium confidence
US 8,354,532Pyrrolo [2,3-d] Pyrimidines as Non-Nucleoside Reverse Transcriptase Inhibitors for Treatment of HIV
Lapsed on the fee record
Ended Jan 15, 2025 · High confidence
Lapsed on the fee recordEnded Jan 15, 2025High confidence
US 10,772,886CXCR-2 Inhibitors for Treating Crystal Arthropathy Disorders
Lapsed on the fee record
Ended Sep 15, 2024 · High confidence
Lapsed on the fee recordEnded Sep 15, 2024High confidence
US 8,227,601Diaryl-Purines, Azapurines and -Deazapurines as Non-Nucleoside Reverse Transcriptase Inhibitor for Treatment of HIV
Lapsed on the fee record
Ended Jul 24, 2024 · High confidence
Lapsed on the fee recordEnded Jul 24, 2024High confidence
10 of 92 records shown.
Pro members see all 92.
Pro members: see all 92 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited